Angiotensin II receptor blockers for preventing the development or progression of microvascular disease due to diabetes

Details for Australian Patent Application No. 2004233597 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Yamagishi, Sho-Ichi

Agent Davies Collison Cave

Pub. Number AU-A-2004233597

PCT Pub. Number WO2004/096211

Priority 103 19 592.0 02.05.03 DE

Filing date 30 April 2004

Wipo publication date 11 November 2004

International Classifications

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

A61K 31/4178 (2006.01)

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2004/096211 Priority application(s): WO2004/096211

26 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004233601-Intravenous injection of non-neurotoxic plasminogen activators for the treating of stroke

2004233596-Solid dosage form comprising desmopressin